AzTrials
AzTrials

Increase HPV Vaccination UptakeNCT02600884

Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention

A study testing Families Talking Together Plus (FTT+HPV) and Brief motivational interviewing (BMI) in people with Increase HPV Vaccination Uptake and Delay Sexual Debut, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research study is to evaluate a brief parent-based adolescent sexual health intervention called Families Talking Together Plus (FTT+). FTT+ is based on an established intervention called Families Talking Together (FTT) and will enhance FTT by adding modules on human papillomavirus (HPV). Read more about this study

Who is it for?
Ages 11 years and olderHealthy volunteers can take part
What is being tested?
Families Talking Together Plus (FTT+HPV) and Brief motivational interviewing (BMI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,183 participants
Where
1 siteUnited States
Study dates
Sep 2015to Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Parent: resides with a child 11-14 years old who attends a participating community center, after-school program, or Boys and Girls Club (BGC)
  • Parent: available for a face-to-face or small group session with the PI or student nurse within 2 months of consenting and assenting to participate in the study
  • Parent: can read, write, and speak English or Spanish
  • Child: between 11-14 years of age

Who cannot join

  • Parent: Without primary custody of child
  • Parent: Incarcerated
  • Parent: Unable to attend a face-to-face session within 2 months

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030

Other trials in United States

About this study

The purpose of this research study is to evaluate a brief parent-based adolescent sexual health intervention called Families Talking Together Plus (FTT+). FTT+ is based on an established intervention called Families Talking Together (FTT) and will enhance FTT by adding modules on human papillomavirus (HPV). The goal of the study is to evaluate whether FTT will help parents increase sexual health communication, delay adolescent sexual debut, and increase HPV vaccination. FTT will be delivered to parents of minority youth and will be delivered by student nurses.

Being tested
Families Talking Together Plus (FTT+HPV), Brief motivational interviewing (BMI)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Families Talking Together Plus (FTT+HPV)Behavioural

    Intervention parents will attend a 1-hour intervention session and receive program materials to use with youth at home and 2 booster phone calls post intervention. Content of the experimental intervention includes parent child sexual health communication and HPV vaccination navigation.

  • Brief motivational interviewing (BMI)Behavioural

    Control parents will attend a 1-hour intervention session and receive program materials to use with youth at home and 2 booster phone calls post intervention. Content of the control intervention includes obesity prevention strategies using motivational interviewing.

Study groups in NCT02600884
Study groupRoleWhat they receive
Families Talking Together Plus (FTT+HPV)ExperimentalParents in the experimental group will attend a 1-hour intervention session, receive program materials to use with youth at home, and receive 2 booster phone calls post-intervention. Content of the experimental intervention includes parent-child sexual health communication and HPV vaccination navigation.
Receives: Behavioral: Families Talking Together Plus (FTT+HPV)
Brief motivational interviewing (BMI)Active comparatorParents in the brief motivational interviewing (BMI) group will attend a 1-hour intervention session, receive program materials to use with youth at home, and receive 2 booster phone calls post-intervention. Content of the control intervention includes obesity prevention strategies using motivational interviewing.
Receives: Behavioral: Brief motivational interviewing (BMI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in parent child communication as assessed by the Families Talking Together Plus HPV (FTT + HPV) survey administered to parents

    The FTT + HPV survey is a survey that has been developed by the investigator for this study. The survey is administered at baseline, 1, and 6 months using iPads and is available as Audio Computer-Assisted Self-Interviews in both English and Spanish.

    Measured: 1 month

  2. Change in parent child communication as assessed by the FTT + HPV survey administered to parents

    Measured: 6 months

  3. Change in intentions for sex as assessed by the FTT + HPV survey administered to youths

    Measured: 1 month

  4. Change in intentions for sex as assessed by the FTT + HPV survey administered to youths

    Measured: 6 months

Secondary outcomes (16)
  1. Change in parental monitoring as assessed by the FTT + HPV survey administered to parents

    Measured: 1 month

  2. Change in parental monitoring as assessed by the FTT + HPV survey administered to parents

    Measured: 6 months

  3. Change in parental involvement as Assessed by the FTT + HPV survey administered to parents

    Measured: 1 month

  4. Change in parental involvement as assessed by the FTT + HPV survey administered to parents

    Measured: 6 months

  5. Change in intentions for communication as assessed by the FTT + HPV survey administered to parents

    Measured: 1 month

  6. Change in intentions for communication as assessed by the FTT + HPV survey administered to parents

    Measured: 6 months

  7. Change in intentions for HPV vaccination of child as assessed by the FTT + HPV survey administered to parents

    Measured: 1 month

  8. Change in intentions for HPV vaccination of child as assessed by the FTT + HPV survey administered to parents

    Measured: 6 months

  9. Change in sexual activity as assessed by the FTT + HPV survey administered to youths

    Measured: 1 month

  10. Change in sexual activity as assessed by the FTT + HPV survey administered to youths

    Measured: 6 months

  11. Change in knowledge of HPV risk factors as assessed by the FTT + HPV survey administered to youths

    Measured: 1 month

  12. Change in knowledge of HPV risk factors as assessed by the FTT + HPV survey administered to youths

    Measured: 6 months

  13. Change in parental communication as assessed by the FTT + HPV survey administered to youths

    Measured: 1 month

  14. Change in parental communication as assessed by the FTT + HPV survey administered to youths

    Measured: 6 months

  15. Change in HPV vaccine received as assessed by the FTT + HPV survey administered to youths

    Measured: 1 month

  16. Change in HPV vaccine received as assessed by the FTT + HPV survey administered to youths

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2015 (estimated)
  2. Study startSep 2015
  3. Primary completionNov 2018
  4. Study completionApr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,183 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02600884
Sponsor's protocol ID
HSC-SN-15-0091
Status last verified
Oct 2023
First submitted
5 Nov 2015
Last updated
3 Nov 2023
Results posted
No
Data monitoring committee
No

Publications

  • Coleman DC, Frederick A, Cron S, Markham C, Guilamo-Ramos V, Santa Maria D. Impact of preparing nursing students to deliver a parent-based sexual health intervention on attitudes and intentions for sexual health education and parent communication counseling: a mixed methods study. BMC Nurs. 2023 Oct 10;22(1):375. doi: 10.1186/s12912-023-01531-2.

    PubMed 37817237
  • Santa Maria D, Markham C, Misra SM, Coleman DC, Lyons M, Desormeaux C, Cron S, Guilamo-Ramos V. Effects of a randomized controlled trial of a brief, student-nurse led, parent-based sexual health intervention on parental protective factors and HPV vaccination uptake. BMC Public Health. 2021 Mar 24;21(1):585. doi: 10.1186/s12889-021-10534-0.

    PubMed 33761920

Questions about this trial

What is this clinical trial studying?

A study testing Families Talking Together Plus (FTT+HPV) and Brief motivational interviewing (BMI) in people with Increase HPV Vaccination Uptake and Delay Sexual Debut, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in parent child communication as assessed by the Families Talking Together Plus HPV (FTT + HPV) survey administered to parents (time frame: 1 month). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02600884, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in